MECHANISMS OF DYSLIPIDEMIA IN CARDIAC MUSCLE PRIOR TO ONSET OF ATHEROSCLEROSIS

动脉粥样硬化发生前心肌血脂异常的机制

基本信息

  • 批准号:
    7959656
  • 负责人:
  • 金额:
    $ 26.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-03-01 至 2010-02-28
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Obesity has reached epidemic dimensions in the United States and correlates with the increased incidence of cardiovascular disease. In obesity, the levels of cholesterol, free fatty acids, and tumor necrosis factor alpha (TNF-alpha) are elevated, and contribute to the increased risk of dyslipidemic cardiomyopathy. We hypothesize that cholesterol, palmitate, and TNF-alpha will induce: (i) cardiac contractile dysfunction via changes in the lipid composition of the membrane, and (ii) activation of intracellular signaling cascades that lead to diminished contractile performance. We will compare cholesterol fed and high fat fed mice with young dyslipidemic (ob/ob) mice, to distinguish cholesterol and lipid toxicity-mediated effects from effects mediated by atherosclerosis, and determine complications due to the onset of insulin resistance in the dyslipidemic in vivo mouse models. High cholesterol content in membranes causes them to become leaky, and in addition decreases the activity of major ion pumps. This leads to disturbed ion homeostasis with intracellular accumulation of sodium and calcium, and contributes to contractile dysfunction. We hypothesize that the energetic state of the myocyte is affected by increased ATP utilization to maintain ion homeostasis. Important questions are to what extent and in what time course leaky membranes cause disturbances in the ion homeostasis and energy metabolism of cardiac myocytes, and whether this causes a mismatch in cardiac energy supply and demand. The prevention of disturbances in membrane lipid homeostasis is a potential therapeutic approach to prevent or delay the cardiovascular complications associated with obesity.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ILKA M PINZ其他文献

ILKA M PINZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ILKA M PINZ', 18)}}的其他基金

MECHANISMS OF DYSLIPIDEMIA IN CARDIAC MUSCLE PRIOR TO ONSET OF ATHEROSCLEROSIS
动脉粥样硬化发生前心肌血脂异常的机制
  • 批准号:
    7720096
  • 财政年份:
    2008
  • 资助金额:
    $ 26.32万
  • 项目类别:
MECHANISMS OF DYSLIPIDEMIA IN CARDIAC MUSCLE PRIOR TO ONSET OF ATHEROSCLEROSIS
动脉粥样硬化发生前心肌血脂异常的机制
  • 批准号:
    7609690
  • 财政年份:
    2007
  • 资助金额:
    $ 26.32万
  • 项目类别:
MECHANISMS OF DYSLIPIDEMIA IN CARDIAC MUSCLE PRIOR TO ONSET OF ATHEROSCLEROSIS
动脉粥样硬化发生前心肌血脂异常的机制
  • 批准号:
    7381067
  • 财政年份:
    2006
  • 资助金额:
    $ 26.32万
  • 项目类别:
MECHANISMS DYSLIPIDEMIA CARDIAC MUSCLE ATHEROSCLEROSIS
血脂异常、心肌动脉粥样硬化的机制
  • 批准号:
    7170231
  • 财政年份:
    2005
  • 资助金额:
    $ 26.32万
  • 项目类别:

相似海外基金

The Role of SECTM1 in Monocyte Biology and Atherosclerosis
SECTM1 在单核细胞生物学和动脉粥样硬化中的作用
  • 批准号:
    10680450
  • 财政年份:
    2022
  • 资助金额:
    $ 26.32万
  • 项目类别:
The Role of SECTM1 in Monocyte Biology and Atherosclerosis
SECTM1 在单核细胞生物学和动脉粥样硬化中的作用
  • 批准号:
    10525199
  • 财政年份:
    2022
  • 资助金额:
    $ 26.32万
  • 项目类别:
SPHINGOLIPID BIOLOGY OF MACROPHAGE IN CORONARY ATHEROSCLEROSIS DEVELOPMENT AND PROGRESSION
冠状动脉粥样硬化发生和进展中巨噬细胞的鞘脂生物学
  • 批准号:
    10542823
  • 财政年份:
    2021
  • 资助金额:
    $ 26.32万
  • 项目类别:
Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis
调节 PCSK9 和治疗动脉粥样硬化的化学生物学
  • 批准号:
    10852687
  • 财政年份:
    2021
  • 资助金额:
    $ 26.32万
  • 项目类别:
Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis
调节 PCSK9 和治疗动脉粥样硬化的化学生物学
  • 批准号:
    10598882
  • 财政年份:
    2021
  • 资助金额:
    $ 26.32万
  • 项目类别:
Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis
调节 PCSK9 和治疗动脉粥样硬化的化学生物学
  • 批准号:
    10370428
  • 财政年份:
    2021
  • 资助金额:
    $ 26.32万
  • 项目类别:
SPHINGOLIPID BIOLOGY OF MACROPHAGE IN CORONARY ATHEROSCLEROSIS DEVELOPMENT AND PROGRESSION
冠状动脉粥样硬化发生和进展中巨噬细胞的鞘脂生物学
  • 批准号:
    10321959
  • 财政年份:
    2021
  • 资助金额:
    $ 26.32万
  • 项目类别:
Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis
调节 PCSK9 和治疗动脉粥样硬化的化学生物学
  • 批准号:
    10631047
  • 财政年份:
    2021
  • 资助金额:
    $ 26.32万
  • 项目类别:
Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis
调节 PCSK9 和治疗动脉粥样硬化的化学生物学
  • 批准号:
    10215201
  • 财政年份:
    2021
  • 资助金额:
    $ 26.32万
  • 项目类别:
Role of Shear-Sensitive Protein HEG1 in Endothelial Biology and Atherosclerosis
剪切敏感蛋白 HEG1 在内皮生物学和动脉粥样硬化中的作用
  • 批准号:
    10459220
  • 财政年份:
    2020
  • 资助金额:
    $ 26.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了